142 related articles for article (PubMed ID: 31879047)
21. RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1.
Chen SH; Gong X; Zhang Y; Van Horn RD; Yin T; Huber L; Burke TF; Manro J; Iversen PW; Wu W; Bhagwat SV; Beckmann RP; Tiu RV; Buchanan SG; Peng SB
Oncogene; 2018 Feb; 37(6):821-832. PubMed ID: 29059158
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effects of isocryptotanshinone on gastric cancer.
Chen ZM; Huang L; Li MM; Meng L; Ying SC; Xu AM
Sci Rep; 2018 Jun; 8(1):9307. PubMed ID: 29915371
[TBL] [Abstract][Full Text] [Related]
23. SIRT1 is downregulated in gastric cancer and leads to G1-phase arrest via NF-κB/Cyclin D1 signaling.
Yang Q; Wang B; Gao W; Huang S; Liu Z; Li W; Jia J
Mol Cancer Res; 2013 Dec; 11(12):1497-507. PubMed ID: 24107295
[TBL] [Abstract][Full Text] [Related]
24. Dihydroartemisinin induces apoptosis and inhibits proliferation, migration, and invasion in epithelial ovarian cancer via inhibition of the hedgehog signaling pathway.
Liu Y; Gao S; Zhu J; Zheng Y; Zhang H; Sun H
Cancer Med; 2018 Nov; 7(11):5704-5715. PubMed ID: 30338663
[TBL] [Abstract][Full Text] [Related]
25. Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling.
Tong Y; Liu Y; Zheng H; Zheng L; Liu W; Wu J; Ou R; Zhang G; Li F; Hu M; Liu Z; Lu L
Oncotarget; 2016 May; 7(21):31413-28. PubMed ID: 27119499
[TBL] [Abstract][Full Text] [Related]
26. Bisphenol S promotes the cell cycle progression and cell proliferation through ERα-cyclin D-CDK4/6-pRb pathway in MCF-7 breast cancer cells.
Lin Z; Zhang X; Zhao F; Ru S
Toxicol Appl Pharmacol; 2019 Mar; 366():75-82. PubMed ID: 30684532
[TBL] [Abstract][Full Text] [Related]
27. Kaempferol suppresses proliferation and induces apoptosis and DNA damage in human gallbladder cancer cells through the CDK4/CDK6/cyclin D1 pathway.
Liu ZQ; Yao GL; Zhai JM; Hu DW; Fan YG
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1311-1321. PubMed ID: 33629301
[TBL] [Abstract][Full Text] [Related]
28. Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma.
Kennedy AL; Vallurupalli M; Chen L; Crompton B; Cowley G; Vazquez F; Weir BA; Tsherniak A; Parasuraman S; Kim S; Alexe G; Stegmaier K
Oncotarget; 2015 Oct; 6(30):30178-93. PubMed ID: 26337082
[TBL] [Abstract][Full Text] [Related]
29. Formononetin promotes cell cycle arrest via downregulation of Akt/Cyclin D1/CDK4 in human prostate cancer cells.
Li T; Zhao X; Mo Z; Huang W; Yan H; Ling Z; Ye Y
Cell Physiol Biochem; 2014; 34(4):1351-8. PubMed ID: 25301361
[TBL] [Abstract][Full Text] [Related]
30. [Artemisinin inhibits proliferation of gallbladder cancer cell lines through triggering cell cycle arrest and apoptosis].
Jia JG; Zhang LG; Guo CX; Wang YG; Chen BL; Wang YM; Qian J
Zhonghua Wai Ke Za Zhi; 2016 Mar; 54(3):222-7. PubMed ID: 26932893
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-545 suppresses cell proliferation by targeting cyclin D1 and CDK4 in lung cancer cells.
Du B; Wang Z; Zhang X; Feng S; Wang G; He J; Zhang B
PLoS One; 2014; 9(2):e88022. PubMed ID: 24505359
[TBL] [Abstract][Full Text] [Related]
32. The role of TRPV1 ion channels in the suppression of gastric cancer development.
Gao N; Yang F; Chen S; Wan H; Zhao X; Dong H
J Exp Clin Cancer Res; 2020 Oct; 39(1):206. PubMed ID: 33008449
[TBL] [Abstract][Full Text] [Related]
33. Antihypertensive drug telmisartan suppresses the proliferation of gastric cancer cells in vitro and in vivo.
Fujita N; Fujita K; Iwama H; Kobara H; Fujihara S; Chiyo T; Namima D; Yamana H; Kono T; Takuma K; Hirata M; Kobayashi K; Kato K; Kamada H; Morishita A; Tsutsui K; Himoto T; Okano K; Suzuki Y; Masaki T
Oncol Rep; 2020 Jul; 44(1):339-348. PubMed ID: 32627043
[TBL] [Abstract][Full Text] [Related]
34. The CDK4/6 inhibitor LY2835219 overcomes vemurafenib resistance resulting from MAPK reactivation and cyclin D1 upregulation.
Yadav V; Burke TF; Huber L; Van Horn RD; Zhang Y; Buchanan SG; Chan EM; Starling JJ; Beckmann RP; Peng SB
Mol Cancer Ther; 2014 Oct; 13(10):2253-63. PubMed ID: 25122067
[TBL] [Abstract][Full Text] [Related]
35. Effects and Mechanisms of Anlotinib and Dihydroartemisinin Combination Therapy in Ameliorating Malignant Biological Behavior of Gastric Cancer Cells.
Luo Q; Zhang S; Zhang D; Feng R; Li N; Chen W; Chen X; Yang S
Curr Pharm Biotechnol; 2021; 22(4):523-533. PubMed ID: 32576126
[TBL] [Abstract][Full Text] [Related]
36. Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression.
Grillo M; Bott MJ; Khandke N; McGinnis JP; Miranda M; Meyyappan M; Rosfjord EC; Rabindran SK
Breast Cancer Res Treat; 2006 Jan; 95(2):185-94. PubMed ID: 16319987
[TBL] [Abstract][Full Text] [Related]
37. CDK4 protein is degraded by anaphase-promoting complex/cyclosome in mitosis and reaccumulates in early G
Chen H; Xu X; Wang G; Zhang B; Wang G; Xin G; Liu J; Jiang Q; Zhang H; Zhang C
J Biol Chem; 2017 Jun; 292(24):10131-10141. PubMed ID: 28446612
[TBL] [Abstract][Full Text] [Related]
38. NHE1 is upregulated in gastric cancer and regulates gastric cancer cell proliferation, migration and invasion.
Xie R; Wang H; Jin H; Wen G; Tuo B; Xu J
Oncol Rep; 2017 Mar; 37(3):1451-1460. PubMed ID: 28098891
[TBL] [Abstract][Full Text] [Related]
39. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
[TBL] [Abstract][Full Text] [Related]
40. Ribociclib, a selective cyclin D kinase 4/6 inhibitor, inhibits proliferation and induces apoptosis of human cervical cancer in vitro and in vivo.
Xiong Y; Li T; Assani G; Ling H; Zhou Q; Zeng Y; Zhou F; Zhou Y
Biomed Pharmacother; 2019 Apr; 112():108602. PubMed ID: 30784916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]